approval
saveIMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approval
community read0 votes
Sponsor: GLAXOSMITHKLINE. Form: INJECTABLE. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalIMITREX (SUMATRIPTAN) — FDA approvalDec 9, 2025 · 299d ago
- approvalIMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approvalDec 9, 2025 · 299d ago
- approvalIMITREX (SUMATRIPTAN SUCCINATE) — FDA approvalDec 9, 2025 · 299d ago
- approvalSUMATRIPTAN SUCCINATE — FDA approvalNov 6, 2025 · 332d ago
- approvalIMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approvalDec 20, 2021 · 1749d ago
- approvalIMITREX (SUMATRIPTAN SUCCINATE) — FDA approvalMar 23, 2021 · 2021d ago
- approvalIMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approvalMar 23, 2021 · 2021d ago
- approvalIMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approvalDec 14, 2017 · 3216d ago
same company · ±60 days · 6
- approvalLAMOTRIGINE: LAMICTAL ODT (LAMOTRIGINE) — FDA approvalJul 23, 2018
- approvalLAMOTRIGINE: LAMICTAL XR (LAMOTRIGINE) — FDA approvalJul 23, 2018
- approvalLAMOTRIGINE: LAMICTAL (LAMOTRIGINE) — FDA approvalJul 23, 2018
- approvalLAMOTRIGINE: LAMICTAL CD (LAMOTRIGINE) — FDA approvalJul 23, 2018
- approvalLAMOTRIGINE: LAMICTAL ODT (LAMOTRIGINE) — FDA approvalJun 27, 2018
- approvalLAMOTRIGINE: LAMICTAL CD (LAMOTRIGINE) — FDA approvalJun 27, 2018
comments(0)
5-min edit window · permanent after that